|
Art. 1: Fundamental Principles
I.
II. Doping contravenes the fundamental principles of DanceSport and medical ethics. Doping is prohibited.
III. Recommending, proposing, authorizing, condoning or facilitating the
use of any substance method covered by the definition of doping or
trafficking herein is also forbidden.
IV. Anti-doping is one of the objects included under Article 2 (c) and (d)
of the IDSF Statutes.
V. Members of the IDSF are obliged to enforce this Code within their own
jurisdictions, as part of the terms of their membership in IDSF.
VI. This Anti-Doping Code is an integral part of the IDSF Statutes.
|
|
|
|
Art. 2: Definitions
I.
[Definitions of Terms]
1. "Doping" means:
a) the use of a substance or
method which is potentially harmful to an athletes' health and capable of
enhancing his or her performance, or either of them, or
b) the presence in an athlete's body of a Prohibited Substance or evidence
of the use thereof, or evidence of the use of a Prohibited Method of
enhancing athletic performance.
2. "Blood Doping"
means the administration of blood, red blood cells or any other blood
products to an athlete, which may or may not be preceded by withdrawal of
blood from an athlete who trains in a blood-depleted state.
3. "Intentional Doping" means Doping in circumstances
where it is established, or may reasonably be presumed, that anyone
knowingly acted or alternatively knowingly failed, refused or neglected to
act with respect to any act or condition involving Doping.
4. "Masking Agent" means any substance or procedure used
for the purpose of or having the effect of altering or suppressing the
integrity of urine or other samples of body tissue or fluid used in Doping
controls.
5. "Participant" means any athlete, coach, trainer,
official, medical or para-medical personnel
working with or in connection with or treating athletes participating in or
preparing for sports competitions of IDSF-granted competitions and all
competitions organized under the authority, whether direct or delegated, of
the IDSF or an IDSF member.
6. "Pharmaceutical, chemical and physical manipulation"
means the use of any substances and methods, including masking agents which
alter, attempt to alter or may reasonably be expected to alter the
integrity and validity of samples of urine or any other bodily fluid or
tissue used in doping controls, including, without limiting the generality
of this definition, catheterisation, urine
substitution and tampering or either of them, inhibition of renal
excretion, such as by probenicid and Related
Substances, and alterations of testosterone and epitestosterone
measurements, such as epitestosterone application
or bromantan administration.
7. "Prohibited Method" means any method so defined in this
Code.
8. "Prohibited Substance" means any substance so defined
in this Code.
9. "Related Substance" means any substance having a
pharmacological action and chemical structure or either of them similar to
a Prohibited Substance or any other substance referred to in this Code,
including but not limited to metabolites of a Prohibited Substance.
10. "Trafficking" means and shall be deemed to occur when
a person, without having expressly received prior authorization from a body
of competent jurisdiction,
a) manufactures, extracts,
transforms, prepares, stores, expedites, transports, imports, exports,
transits, offers subject to payment or free of charge, distributes, sells,
exchanges, undertakes the brokerage of, obtains in any form, prescribes,
commercializes, makes over, accepts, possesses, holds, buys or acquires
Prohibited Substances in any manner;
b) takes any measures to assist or achieve the ends described in the last
subparagraph hereof, including financing the same in any way or serves as
an intermediary for their financing, provokes or is implicated in any way
in the consumption or use of such substances, or establishes means of
procuring or consuming such substances;
c) is a party to Prohibited Methods.
11.
"Use" means the application, ingestion, injection or consumption
by any means whatsoever of any Prohibited Substance, or the use of any
Prohibited Method, and, without limiting the generality of that definition,
includes counselling the use of, permitting the
use of or condoning the use of any prohibited substance or prohibited
method.
12. "Member" means an IDSF member organization.
13. "Anti-Doping Representative" is an official of the
IDSF who is a member of the IDSF Presidium and who is appointed to that
office from time to time by the IDSF Presidium.
II. [List of Prohibited Substances and Prohibited Methods]
The International Olympic Committee's list or lists of Prohibited
Substances and Prohibited Methods published by the IOC from time to time,
is hereby incorporated as an integral part of this Code. This list shall be
constantly reviewed by the Anti-Doping Representative, who may propose
additions or amendments to it. Such addition or amendment must be approved
by the General Meeting, and shall come into force three (3) months from the
date of such approval. Additions or amendments must be codified in Appendix
A of this Anti-Doping Code below V. Additional Regulations.
|
|
Back to top
|
|
Art. 3: Scope
I.
[Application]
1. This Code applies to all Participants.
2. Each Member must inform its registered member dancers, trainers
and functionaries about this Anti-Doping Code, its Participants by handing
them out a copy of this Code. Any Member that nominates a Participant to
any IDSF-granted DanceSport competition is deemed
to have recognized this Anti-Doping Code and to undertake to nominate to
IDSF-granted DanceSport competitions only
Participants who have agreed to comply with all of the duties set out in
and flowing from this Anti-Doping Code and who have signed the
corresponding forms of consent (Appendix B).
3. Participants must, before they take part in an IDSF-granted DanceSport competition, agree to comply with this
Anti-Doping Code by the forms of consent codified in Appendix B of this
Anti-Doping Code. Signed forms can either be sent by the Participants to
the Member who is nominating the Participant or to the organizer of the DanceSport competition; the latest possibility being to
sign the forms at checking in for the Dance Sport competition. In any case,
the forms must then be forwarded to the Anti-Doping Representative.
4. At every IDSF-granted competition, a copy of this Anti-Doping
Code and of the Competition Rules must be held ready for consultation.
5. All athletes are subject to doping controls (urine analyses,
blood tests and other authorized techniques for detecting Prohibited
Substances or Methods).
6. Notwithstanding the obligations of other participants to comply
with the provisions of this Code, it is the personal responsibility of any
athlete subject to the provisions of this Code to ensure that he/she does
not use or allow the use of any prohibited substance or any prohibited
method.
7. No athlete shall be allowed to compete in his/her national
championships, nor shall a member nominate an athlete to an IDSF-granted
competition, unless and until such athlete agrees to subject him/herself to
out-of-competition testing by both the Member and the IDSF.
8. Every Member shall inform the IDSF Anti-Doping Representative of
any positive result(s) obtained in the course of doping controls carried
out by that Member.
II. [Responsibility for Doping Control]
1. At all international IDSF-granted DanceSport
competitions according to Rule 5 IDSF Competition Rules, the IDSF may, by
decision of the Anti-Doping Representative, transfer and assign its
responsibility for doping controls to the Member in whose jurisdiction the
competition takes place, or to the promoter of the competition, provided
always that if in the opinion of the Anti-Doping Representative, the Member
or the promoter may not discharge IDSF's
responsibilities for doping control in a satisfactory manner, the
Anti-Doping Representative may make other arrangements which in her or its
discretion are deemed to be satisfactory.
2. It is a condition of membership of the IDSF that a Member
includes within its constitution or statutes or bylaws or competition
rules:
a) a
provision obliging that Member to conduct out-of-competition doping
controls, a report of which must be submitted to the IDSF annually; and
b) a provision allowing the IDSF to conduct doping controls at that
Member's National Championships or any similar meeting; and
c) a provision allowing the IDSF to conduct out-of-competition tests on
that Member's athletes.
d) It is the duty of any Member or officer of a Member to assist the IDSF
and, if appropriate or deemed appropriate by the Anti-Doping
Representative, other Members in the carrying out of such testing. Any
Member whose representative is found to be or to have been preventing,
delaying, impending, hindering or otherwise obstructing the carrying out of
such tests shall be liable to sanctions under the Statutes of the IDSF.
3. Out-of-competition
testing of athletes recorded on the IDSF Ranking List is implemented by
WADA. Out-of-competition testing of other athletes is implemented by
Members.
4. In order to more fully and perfectly implement this Code and its
policies, the following applies regarding the recognition of results from
doping controls:
a) Every Member shall inform the
IDSF Anti-Doping Representative of any positive result(s) obtained in the
course of doping controls carried out by that member. These findings shall
be considered by the Anti-Doping Representative who shall, in her/his
absolute discretion, on behalf of all members of the IDSF, recognize any
positive result(s) obtained. These positive results of doping controls
carried out by that member will then be final and binding upon all members,
who shall take all reasonably necessary action to render such decision
effective.
b) Where doping control has been carried out by the IDSF, every member
shall recognize the results of such doping controls and shall take all
necessary action to render such decision effective.
c) The Anti-Doping Representative may, on behalf of all members of the
IDSF, recognize the results of doping control carried out by a sporting
body other than the IDSF, or by a member of that sporting body under rules
and procedures different from those of the IDSF, if he/she is satisfied
that the testing was properly carried out and the rules of the body
conducting these tests afford sufficient protection to athletes.
d) Where it is proposed to recognize the results of doping controls carried
out by a sporting body other than the IDSF, or by a member of that sporting
body under rules and procedures different from those of the IDSF, an
athlete likely to be affected shall be given notice in writing. Should
he/she wish to make representations in writing, she or he shall deliver
them to the Anti-Doping Representative within a month after the date of the
notification of the athlete.
e) If the Anti-Doping Representative decides to recognize the result of
doping controls carried out by a sporting body other than the IDSF, then
the athlete shall be deemed to have breached the relevant IDSF Rule and
will be subject to the same sanctions and procedures according to this Code
as an athlete who has done so. All members shall take all necessary action
to ensure that this decision is effective.
|
|
Back
to top
|
|
Art. 4: Implementation of Doping Controls
I.
[Group of Athletes to be Tested]
Doping controls must be carried out
1. in Pair Competitions, on six athletes, three of each sex: one
member of the winning pair and five further athletes all to be chosen by
the drawing of lots;
2. in Team Competitions, on six athletes, three of each sex: one
member of the winning team and five further athletes all to be chosen by
the drawing of lots.
3. those athletes whom the IDSF has actual
reason to suspect of having contravened the Anti-Doping Code.
II. [Obligation to Tolerate Controls and Furnish Information]
Athletes must tolerate the carrying out of doping controls and, insofar as
is necessary, must actively participate, in particular by means of
declaring such medications as they have taken in the three days prior to
the carrying out of the doping control. These declared medications shall be
noted in the protocol of the doping control.
III. [Nomination of a Doping Control Team]
1. The organizer of the competition has to appoint a Doping Control
Team (DCT) which carries out doping controls on site.
2. A DCT comprises at least two persons (the Head of the team and
one or more helpers). The sex of the athletes to be tested is to be taken
into consideration when choosing the DCT. At least one member of the DCT
must be the same sex as the athletes. The Head of the DCT must be a
physician.
IV. [Carrying Out the Doping Controls on Site] The DCT shall travel
to the competition without prior announcement and shall there make themselves known to the organizer of the event, or the
responsible functionary. The latter then leads the DCT without delay to the
rooms which have been set aside for the doping controls and, if necessary,
orders any necessary changes to be made in order to guarantee that the
doping control tests can be carried out without complaint and in keeping
with the respective rules.
V. [Drawing Lots to Determine Athletes to be Tested] If required
according to Art. 4, para. 1, the Head of the DCT
shall draw lots to determine the athletes to be tested.
VI. [Notification of the Athletes]
1. Immediately after the end of the competition or following the
announcement of the final result, those athletes who have been chosen (by
lots) to undergo doping controls are provably requested to make their way
immediately to the doping control room. 2. The athlete is entitled
to present himself/herself for the doping control with a person of their
choice (official, trainer, physician, masseur, etc.). 3. Moreover,
the athlete shall be informed of the possible consequences which shall take
effect should he/she not present himself/herself for testing. 4. As
a matter of principle the doping controls should be carried out with as
little delay as possible.
VII. [Procedure for Urine Controls]
1. In addition to the athlete and the person accompanying him/her,
only the following persons should be present in the control room:
a) A Representative of the
organizer,
b) The Doping Control Team.
2. Upon arrival in the
doping control room the athlete shall identify himself/herself beyond doubt
(licence, passport, ID card, etc.).
3. The time of arrival in the doping control room and personal
details shall be entered into the relevant documents by the DCT.
4. The athlete himself/herself chooses the urine sample container
(beaker). At least 75 millilitres of urine is to
be passed into the container under the supervision of a same-sex member of
the DCT. Subsequently, the athlete chooses two containers bearing a special
code each containing two small bottles marked (engraved) with an identical
code number and the letters "A" or "B". The athlete
himself/herself fills the collected urine into the two small bottles
(bottle "A" is filled two-thirds full; bottle "B" is
filled one-third full). Then the bottles are closed. It is appropriate to
check that the bottles are sealed properly. Then the bottles are duly stored
in the containers. A special seal is applied to the container.
5. The time of urine sampling and the code numbers are noted in the
protocol. Likewise, any medications taken in the previous 72 hours
(according to statements made by the athlete) are also noted down in the
protocol.
6. After the athlete has made a final check of the data and the Versapak, he/she signs the protocol and thus confirms
that the doping control has been carried out properly. Furthermore, the
protocol is also signed by the Head of the DCT, the person accompanying the
athlete (if present) as well as the Anti-Doping Representative (if
present).
7. The athlete receives a copy of the protocol.
8. The protocols as well as the containers are packed, sealed and
immediately conveyed to the organizer of the competition by the DCT after
the entire doping control procedure has been completed. The organizer
provides the further transportation of the urine samples to the respective
laboratory.
9. In the event of the athlete being unable to pass sufficient urine
after one or more attempts, the available amount shall be kept safe in a Versapak bottle chosen by the athlete himself/herself.
Upon further passing of urine, the athlete opens the bottle him-self/herself
and mixes the "old" urine with the "new" urine. The
amount of urine now present is divided between the two bottles following as
described above. The procedure then continues as previously described.
VIII.[Procedure for Blood Controls]
1. Blood samples shall only be taken by medically qualified
personnel. Any official conducting Anti-Doping blood sampling shall provide
the athlete with evidence of medical qualification before blood samples are
taken.
2. No samples shall be taken unless an athlete has had the blood
sampling procedures explained to him or her and has signed the form of
consent to blood testing. If an athlete refuses to sign the form of
consent, a sample shall not be taken from him or her, provided always that
such a failure, other than in the circumstances set out below, will be
deemed to be an unauthorized refusal to submit to doping control.
3. The equipment necessary to conduct blood sampling shall consist
of the following items in sufficient quantity for each test. Items a) to f)
inclusive shall be of a quality suitable for blood sampling for medical
purposes and items a) to f) inclusive shall be disposable and must be
sterile if required by competent medical opinion:
a) Venous canulae
b) Vacuum tubes
c) Plastic syringe-like holders for the vacuum sample tubes
d) Shipping containers
e) Sterile disinfectant serviettes
f) Tourniquet
Items a) to d) inclusive, which are specific to an individual test, shall
be contained within a module (Blood Sampling Module).
4. The athlete shall choose
a Blood Sampling Module from a selection of at least two modules. The
athlete shall select a blood sampling module and sampling shall begin. The
official conducting blood sampling shall apply a tourniquet to the
athlete's arm. No attempt shall be made to take blood from any other area
of the athlete's body. The head of the DCT shall clean the skin with the
supplied sterile disinfectant serviette and shall take the blood sample
from a superficial vein, preferably in the anti-cubital
region. The Head of the DCT shall attempt to do this as painlessly as
possible. Sufficient blood to fill four of the blood sample tubes to be
found in the Blood Sampling Module shall be withdrawn from an athlete
during blood sampling.
5. An athlete shall be entitled to refuse to provide a blood sample
if:
a) the person intending to
conduct blood sampling is unable to provide evidence of an officially
recognized professional medical qualification;
b) the items a) and d) above under No. 3, to be found in the blood sampling
module, are not contained within clean, sealed packaging or if such
packaging is not intact;
c) an official proposes or attempts to withdraw more than 25 millilitres of blood from the athlete.
6. The blood shall be
withdrawn from the athlete into the four vacuum tubes. These tubes will be
put directly into the transportation containers for the A & B Samples
and these containers shall be immediately sealed. Each sample tube shall be
marked with a code number. This code number should be written by the
relevant official on the athlete's Doping Control Form. The athlete should
ensure that the code on the sample tubes corresponds to that entered by the
official on the form.
7. The tested athlete, the accompanying person (if present), the
Anti-Doping Representative (if present) and the head of the DCT must all
sign the Doping Control Form, confirming that the above procedures were
carried out, provided always that if an athlete or any other person thinks
that the procedures were not carried out satisfactorily, she or he may
declare so on the Doping Control Form and state his or her reasons for
dissatisfaction. In the absence of any such declaration, the athlete shall
be deemed to have waived any alleged procedural breach.
8. The athlete shall also provide details on the Doping Control Form
of any medication recently taken by him or her and of whether he or she has
received a blood transfusion during the preceding six months.
9. The protocols as well as the containers are packed, sealed and
immediately conveyed to the organizer by the DCT. The organizer provides
the further transportation to the respective laboratory.
IX. [Storage and Despatch of Samples]
1. All persons who have physical custody of such samples are obliged
at all times to preserve and protect them and to provide evidence of
uninterrupted supervision and control of the same by authorized personnel,
in order to prevent tampering and in order to ensure that the Anti-Doping
policy of the IDSF may not be called into question or fall into disrepute,
and the Presidium is authorized to take all measures it deems necessary in
its absolute discretion against persons and Members who fail to comply with
this duty.
2. Before containers containing any urine or blood are packed, it
should be confirmed that all samples taken are present and that the number
is in accordance with the list of code numbers. All samples should, if
possible, be stored in a refrigerator or freezer.
3. The main "A" and reserve "B" samples should
be placed in a sealed, protective suitable outer container and should be despatched to the laboratory as soon as possible after
the doping control has been carried out.
4. If at all possible, the outer container should not be opened
during transit to the laboratory. The IDSF will provide identification
labels, if required, for customs purposes. The opening of the outer
container will not, of itself, invalidate the doping control.
5. Samples provided by athletes for the purpose of doping controls
immediately become the property of the IDSF.
X. [Procedure Following Refusal to Submit to Doping Control] If an
athlete refuses to provide a urine or blood sample, the possible
consequences shall be presented to him/her. The refusal to allow a doping
control to be carried out is subject to punishment pursuant to Art. 5, para. 7. If the athlete continues to refuse, this fact
shall be recorded in the protocol. This note shall be signed by the IDSF
Anti-Doping Representative (if present) and the Head of the DCT. The
protocol shall immediately be passed on to the IDSF Anti-Doping
Representative.
XI. [Analysis of the Samples] The analysis of the urine and blood
samples may only be carried out by IOC-accredited laboratories. The
analyses are to be carried out as soon as possible after the samples have
reached the laboratory. The analyses are to be carried out using recognized
methods. The laboratory shall make the results of the analyses available in
writing.
XII. [Announcing the Results of the Analysis to the Athlete]
1. The laboratory informs the organizer of the results of the
analysis in writing and the organizer undertakes to pass on the results:
a) to the athlete, in the event
of a negative result;
b) to the athlete, in the event of a positive result, with the request that
he/she comment on the matter or provide information on the desired further
procedure (analysis of the "B" sample), to the Anti-Doping
Representative and to the Managing Committee of the Presidium of the IDSF.
2. If the athlete desires
that the "B" sample be analysed, the
organizer arranges the analysis. The athlete involved shall have the right
to be present while the analysis is carried out, or that a person
designated by him/her be present. The athlete
shall carry the resulting costs (in the event of a positive result)
himself/herself.
3. The athlete shall be granted the possibility of a
"hearing". The result of the "B" sample shall be seen
as final. Further analyses shall not be permitted.
XIII. [Costs] The IDSF carries the costs of the sampling and testing of the
samples taken. In the event of sanctions being imposed (Art. 6 para. 5 No. 1), the athlete
shall carry the costs of the sampling and testing.
|
|
Back to top
|
|
Art. 5: Sanctions
I.
[Principles] It is an athlete's duty to
ensure that no substance prohibited under this Code enters his body tissues
or fluids. Bans must be imposed in relation to the individual
responsibility of the athlete.
II. [Rules of Evidence]
1. A positive blood or urine sample is prima facie evidence of an
athlete's being responsible for a doping offence.
2. Evidence obtained from metabolic profiles and/or isotopic ratio
measurements may be used to draw definitive conclusions regarding the use
of anabolic androgenic steroids.
3. The success or failure of the use of a prohibited substance or
prohibited method is immaterial. It is sufficient that the prohibited
substance or prohibited method was used or attempted for the offence of
doping to be considered as having been committed and consummated.
III. [Sanctions] In a case of doping,
1. the penalties for a first offence are as follows:
a) If the prohibited substance
used is ephedrine, phenylpropanolamine, pseudoephedrine, caffeine, strychnine or related
substances:
aa) A written warning;
bb) A ban on participation in one or several sports competitions in any
capacity whatsoever;
cc) A fine of up to CHF 20,000.00;
dd) Suspension from any competition for a period
of one to six months.
b) If the prohibited substance
used is one other than those referred to in paragraph a) above:
aa) A ban on participation in one or several sports
competitions in any capacity whatsoever;
bb) A fine of up to CHF 20,000.00;
cc) Suspension from any competition for a minimum period of two years,
provided always that in the case of specific, exceptional circumstances to
be evaluated in the first instance by the competent body, there may be a
provision for a possible modification of the two-year sanction.
2. In case of
a) Intentional Doping;
b) The use of a Masking Agent;
c) Manoeuvres or manipulation that may prevent or
distort any test contemplated in this Code;
d) Complicity or other forms of involvement in an act of doping by members
of a medical, pharmaceutical or related profession, the sanctions are as
follows:
aa) If the prohibited substance used is ephedrine, phenylpropanolamine, pseudoephedrine,
caffeine or strychnine and related substances:
aaa) A ban on participation in one or several sports
competitions in any capacity whatsoever;
bbb) A fine of up to CHF 20,000.00;
ccc) Suspension from any competition for a period
of two to eight years.
bb) If the prohibited substance used is one other than those
referred to in paragraph 1. above or if it is a repeat offence (a repeat
offence being constituted by a further case of doping perpetrated within a
period of ten years after the preceding sanction, whatever form it took and
whatever the reason for it, became final):
aaa) A life ban on participation in any sports event in any
capacity whatsoever;
bbb) A fine of up to CHF 200,000.00;
ccc) Suspension (between four years and life)
from all sports competition.
IV. [Suspension] The athlete shall be suspended from any further
competition from the time the IDSF Anti-Doping Representative reports a
positive blood or urine sample ("A" sam-ple)
to any other member of the Managing Committee/Sports Court (Art. 6 II).
V. [Disqualification] Any case of doping during a competition
automatically leads to invali-dation of the
result obtained (with all its consequences, including forfeit of any medals
and prizes), irrespective of any other sanction that may be applied,
subject to the provisions of paragraph III of this article. In the event of
a dancer from a Formation Team being dis-qualified,
this disqualification extends to the entire Formation Team.
VI. [Effect] The penalty for an offence tted
by a competitor and detected on the occasion of an out-of-competition test
shall be the same, mutatis mutandis, and shall take effect from the date
the positive result was recorded.
VII. [Refusal to Provide Samples] The refusal to submit to doping
control or to provide a blood or urine sample is a frustration of evidence
and a violation of the athlete's coopera-tion
duties. An athlete shall only be entitled to refuse to provide a blood or
urine sample in circumstances where the mandatory procedures and safeguards
set out in the IDSF Anti-Doping Code and its other Anti-Doping regulations
are not observed.
1. In case of refusal to provide a sample the penalties for a first
offence are as follows:
a) A warning;
b) A ban on participation in one or several sports competitions in any
capacity what-soever;
c) A fine of up to CHF 20.000,00;
d) Suspension from any competition for a period of one to six months.
2. In case of refusal to provide
a sample the penalties for a second offence are as follows:
a) A ban on participation in one
or several sports competitions in any capacity what-soever;
b) A fine of up to CHF 20,000.00;
c) Suspension from any competition for a period of two to eight years.
3. In case of refusal to
provide a sample the penalties for a repeated offence are as follows:
a) A life ban on participation in
any sports event in any capacity whatsoever;
b) A fine of up to CHF 200,000.00;
c) Suspension (between four years and life) from all sports competition.
VIII. [Trafficking in
Prohibited Substances] The penalties for trafficking in prohibited
substances other than in the normal course of a recognized profession or
trade are as follows:
1. For trafficking in Prohibited Substances the penalty will be
suspension for life from participation in any sports organization, body,
activity or event in any capacity whatsoever. In addition, the offence(s)
may be reported to the competent administrative and judicial authorities by
any natural or legal person. Any attempt to traffic shall be penalized in
the same manner as the act of trafficking itself.
2. Ignorance of the nature or composition of the Prohibited
Substances or the nature or effects of the Prohibited
Methods in question does not constitute attenuating circumstances or
grounds for exemption from punishment for trafficking or attempted
trafficking.
IX. [Concurrent Penalties and Conditions] The penalties set out in
this Code may be applied concurrently insofar as they are compatible and
may be accompanied by measures prescribing regular or unannounced tests of
the athlete concerned over a specified period of time.
X. [Sanctions imposed by Members] An athlete may only be sanctioned
once for a Doping offence. Members must refrain from imposing sanctions
against an athlete if IDSF is taking up the case against her or him
according to this Code. The regulations for the recognition of doping
controls (Art. 3 para. 2 No. 4) apply also to the
recognition of sanctions respectively.
XI. [Medical Exemptions] An athlete may request the Anti-Doping
Representative to grant prior exemption allowing him/her to take a
substance normally prohibited under the IDSF Rules. Such an exemption will
only be granted in cases of clear and compelling clinical need.
|
|
Back to top
|
|
Art. 6: Procedure in the Event of
a Positive Doping Sample
I. [Suspension] In the event of an athlete's "A" sample
testing positive, the Managing Committee of the IDSF Presidium shall suspend
the athlete if this seems necessary in the interests of fair competition.
II. [Invoking the Sports
Court]
1. In the event of a positive "A" sample, the Anti-Doping
Representative shall call upon the Managing Committee. The Managing
Committee takes on the role of a Sports Court of the IDSF.
2. The Managing Committee decides on whether to introduce sanctions
pursuant to Art. 5 of this Code, as well as on when to lift the suspension.
III. [Procedure] 1. The Managing Committee meets in camera.
2. The case is heard. With the agreement of the involved persons and
in the event of summary proceedings, the decision can be made without a
hearing.
3. The persons involved shall be given the opportunity to state
their case orally or in writing. They may take counsel.
4. The Managing Committee shall determine the time and place for the
hearing. The persons involved shall be informed by registered mail of the
date of the hearing at least two weeks prior to it.
5. In the event of the persons involved not appearing after proper invitation, the Managing Committee may base its decision
on the records without a hearing.
6. The Chair of the Managing Committee may, within his/her
jurisdiction, allow written, well-founded urgent decisions to be taken,
insofar as this is deemed necessary in order to uphold the Federation
Rules, sporting discipline or the rights of the athlete. A complaint may be
lodged against urgent proceedings within the period of one week. The
Managing Committee decides on the complaint.
7. The Managing Committee shall decide by majority vote. Less
significant proceedings, in particular such proceedings in which the fault
is negligible, may be dismissed on the grounds of triviality.
8. All decisions made by the Managing Committee shall be justified in
writing and signed by all its members.
IV. [Reasons for Exclusion]
1. A particular member of the Managing Committee shall be excluded
from taking part in a proceedings if
a) the member himself/herself or
an athlete from his/her national federation is involved in the case;
b) someone involved in the case
aa) is the fiancé/fiancée of a member of the Managing
Committee, or
bb) is or was the husband/wife (i.e., even if the marriage no longer exists
according to the respective national law), or
cc) is or was related in the direct line or by marriage, in the collateral
line twice re-moved or by marriage once removed.
2. Members of the Managing
Committee may declare themselves biased or may be declined by another
member on the grounds of suspicion of bias. In the latter case, a
challenging petition is to be justified in writing and to be attached to
the challenging petition without delay subsequent to its being made known.
The Chair of the Managing Committee decides on the justification.
3. In the event of a member of the Managing Committee being excluded
pursuant to Art. 6 para. 4, no. 1 or no. 2, the
equivalent number of members shall be nominated from the Presidium.
V. [Costs]
1. The Managing Committee decides on the costs of the case.
2. In the event of sanctions being imposed, the athlete shall carry
the costs of the case. Otherwise the IDSF shall carry the costs.
3. Costs eligible for cost assessment are:
a) Expenditures for witnesses and
evidence,
b) Necessary expenses of the persons involved (travel costs, accommodation,
meals), including the panel of judges.
Expenses incurred through drawing on or authorizing third parties are not
eligible for cost assessment.
VI. [Right of Appeal]
1. There is no right of appeal in the law courts against decisions
taken by the Sports Court.
2. An appeal may be lodged with the Court of Arbitration for Sport, Lausanne, against
decisions taken by the Sports
Court.
|
|
Back to top
|
|
Art. 7: Taking Effect
This Anti-Doping Code has been approved by the 2001 IDSF General Meeting.
It will be effective from January 1, 2002. Appendix A: Prohibited Classes
of Substances and Prohibited Methods
[SUBSTITUTES
APPENDIX A OF THE OMAC 1999 OLYMPIC MOVEMENT ANTI-DOPING CODE APPENDIX A,
as at 1st September 2001]
I. PROHIBITED CLASSES OF SUBSTANCES
A. Stimulants
Prohibited substances in class (A) include the following examples:
amineptine, amiphenazole,
amphetamines, bromantan, caffeine*,
carphedon, cocaine, ephedrines**,
fencamfamin, formoterol***,
mesocarb, pentetrazol,
pipradrol, salbutamol***,
salmeterol***, terbutaline***,
... and related substances.
* For caffeine the definition of a positive is a concentration in urine
greater than 12 micrograms per millilitre.
** For cathine, the definition of a positive is a
concentration in urine greater than 5 micrograms per millilitre.
For ephedrine and methylephedrine, the definition
of a positive is a concentration in urine greater than 10 micrograms per millilitre. For phenylpropanolamine
and pseudoephedrine, the definition of a positive
is a concentration in urine greater than 25 micrograms per millilitre.
*** Permitted by inhaler only to prevent and/or treat asthma and
exercise-induced asthma.
Written notification of asthma and/or exercise-induced asthma by a
respiratory or team physician is necessary to the relevant medical
authority.
NOTE: All imidazole preparations are acceptable
for topical use. Vasoconstrictors may be administered with local anaesthetic agents. Topical preparations (e.g. nasal, ophthalmological, rectal) of
adrenaline and phenylephrine are permitted.
B. Narcotics
Prohibited substances in class (B) include the following examples:
buprenorphine, dextromoramide,
diamorphine (heroin), methadone, morphine, pentazocine, pethidine, ...
and related substances.
NOTE: codeine, dextromethorphan, dextropropoxyphene, dihydrocodeine,
diphenoxylate, ethylmorphine,
pholcodine, propoxyphene
and tramadol are permitted.o2
C. Anabolic agents
Prohibited substances in class (C) include the following examples:
1. Anabolic androgenic steroids
a.
clostebol, fluoxymesterone,
metandienone, metenolone,
nandrolone, 19-norandrostenediol,
19-norandrostenedione, oxandrolone, stanozolol, ... and related substances.
b.
androstenediol, androstenedione,
dehydroepiandrosterone (DHEA), dihydrotestosterone, testosterone*, ... and related
substances.
Evidence obtained from metabolic profiles and/or isotopic ratio
measurements may be used to draw definitive conclusions.
* The presence of a testosterone (T) to epitestostrone
(E) ratio greater than six (6) to one (1) in the urine of a competitor
constitutes an offence unless there is evidence that this ratio is due to a
physiological or pathological condition, e.g. low epitestosterone
excretion, androgen producing tumour, enzyme
deficiencies.
In the case of T/E greater than 6, it is mandatory that the relevant
medical authority conducts an investigation before the sample is declared
positive. A full report will be written and will include a review of previous
tests, subsequent tests and any results of endocrine investigations. In the
event that previous tests are not available, the athlete should be tested
unannounced at least once per month for three months. The results of these
investigations should be included in the report. Failure to co-operate in
the investigations will result in declaring the sample positive.
2. Beta-2 agonists
bambuterol, clenbuterol,
fenoterol, formoterol, reproterol, salbutamol*, salmeterol*, terbutaline*, ... and related substances.
*Authorized by inhalation as described in Article (I.A.).
For salbutamol the definition of a positive under
the anabolic agent category is a concentration in urine greater than 1000 nanograms per millilitre.o3
D. Diuretics
Prohibited substances in class (D) include the following examples:
acetazolamide, bumetanide,
chlortalidone, etacrynic
acid, furosemide, hydrochlorothiazide, mannitol*, mersalyl, spironolactone, triamterene,
... and related substances.
* Prohibited by intravenous injection.
E. Peptide hormones, mimetics and analogues
Prohibited substances in class (E) include the following examples and their
analogues and mimetics:
1. Chorionic Gonadotrophin
(hCG) prohibited in males only;
2. Pituitary and synthetic gonadotrophins
(LH) prohibited in males only;
3. Corticotrophins (ACTH, tetracosactide);
4. Growth hormone (hGH);
5. Insulin-like Growth Factor (IGF-1);
and all the respective releasing factors and their analogues;
6. Erythropoietin (EPO);
7. Insulin;
permitted only to treat athletes with certified insulin-dependent diabetes.
Written certification of insulin-dependent diabetes must be obtained from
an endocrinologist or team physician.
The presence of an abnormal concentration of an endogenous hormone in class
(E) or its diagnostic marker(s) in the urine of a competitor constitutes an
offence unless it has been proven to be due to a physiological or
pathological condition.
II. PROHIBITED METHODS
The following procedures are prohibited:
1. Blood doping: means the administration of blood, red blood
cells/and or related blood products to an athlete, which may be preceded by
withdrawal of blood from the athlete, who continues to train in such a
blood-depleted state.
2. Administering artificial oxygen carriers or plasma expanders;
3. Pharmacological, chemical and physical manipulation.o4
III. CLASSES OF SUBSTANCES PROHIBITED IN CERTAIN CIRCUMSTANCES
A. Alcohol
Where the rules of a responsible authority so provide, tests will be
conducted for ethanol.
B. Cannabinoids
Where the rules of a responsible authority so provide, tests will be
conducted for cannabinoids (e.g. marijuana,
hashish). At the Olympic Games, tests will be conducted for cannabinoids. A concentration in urine of 11-nor-delta
9-tetrahydrocannabinol-9-carboxylic acid (carboxy-THC)
greater than 15 nanograms per millilitre
constitutes doping.
C. Local anaesthetics
Injectable local anaesthetics
are permitted under the following conditions:
a. bupivacaine, lidocaine,
mepivacaine, procaine, and related substances,
can be used but not cocaine. Vasoconstrictor agents may be used in
conjunction with local anaesthetics;
b. only local or intra-articular injections may
be administered;
c. only when medically justified.
Where the rules of a responsible authority so provide, notification of
administration may be necessary.
D. Glucocorticosteroids
The systemic use of glucocorticosteroids is
prohibited when administered orally, rectally, or by intravenous or
intramuscular injection.
When medically necessary, local and intra-articular
injections of glucocorticosteroids are permitted.
Where the rules of a responsible medical authority so provide, notification
of administration may be necessary.
E. Beta-blockers
Prohibited substances in class (E) include the following examples:
acebutolol, alprenolol,
atenolol, labetalol, metoprolol, nadolol, oxprenolol, propranolol, sotalol, and related substances.
Where the rules of a responsible authority so provide, tests will be
conducted for beta-blockers.
SUMMARY OF URINARY CONCENTRATIONS ABOVE FOR WHICH IOC-ACCREDITED
LABORATORIESo5 MUST REPORT FINDINGS FOR SPECIFIC SUBSTANCES
caffeine > 12 micrograms/millilitre
carboxy-THC > 15 nanograms/millilitre
cathine > 5 micrograms / millilitre
ephedrine > 10 micrograms / millilitre
epitestosterone > 200 nanograms
/ millilitre
methylephedrine > 10 micrograms / millilitre
morphine > 1 microgram / millilitre
19-norandrosterone > 2 nanograms /millilitre in males
19-norandrosterone > 5 nanograms/millilitre in
females
phenylpropanolamine > 25 micrograms / millilitre
pseudoephedrine > 25 micrograms / millilitre
salbutamol
(as stimulant) > 100 nanograms/millilitre
(as anabolic agent) >1000 nanograms/millilitre
T/E ratio > 6
IV. OUT-OF-COMPETITION TESTING
Unless specifically requested by the responsible authority,
out-of-competition testing is directed solely at prohibited substances in
class I.C (Anabolic Agents), I.D (Diuretics), I.E (Peptide Hormones, Mimetics and Analogues), and II. (Prohibited Methods).
LIST OF EXAMPLES OF PROHIBITED SUBSTANCES AND PROHIBITED METHODS
CAUTION: This is not an exhaustive list of prohibited substances.
Many substances that do not appear on this list are considered prohibited
under the term "and related substances".
Athletes must ensure that any medicine, supplement, over-the-counter
preparation or any other substance they use does not contain any Prohibited
Substance.
STIMULANTS:
amineptine, amfepramone,
amiphenazole, amphetamine, bambuterol,
bromantan, bupropion;
caffeine, carphedon, cathine,
cocaine, cropropamide, crotethamide,
ephedrine, etamivan, etilamphetamine,
etilefrine, fencamfamin,
fenetylline, fenfluramine,
formoterol, heptaminol,
mefenorex, mephentermine,
mesocarb, methamphetamine, methoxyphenamine,
methylenedioxyamphetamine, methylephedrine,
methylphenidate, nikethamide, norfenfluramine,
parahydroxyamphetamine, pemoline,
pentetrazol, phendimetrazine,
phentermine, phenylephrine,
phenylpropanolamine, pholedrine,
pipradrol, prolintane, propylhexedrine, pseudoephedrine,
reproterol, salbutamol,
salmeterol, selegiline,
strychnine, terbutaline,
NARCOTICS:
buprenorphine, dextromoramide,
diamorphine (heroin), hydrocodone,
methadone, morphine, pentazocine, pethidine,
ANABOLIC AGENTS:
androstenediol, androstenedione,
bambuterol, boldenone, clenbuterol, clostebol, danazol, dehydrochlormethyltestosterone,
dehydroepiandrosterone (DHEA), dihydrotestosterone, drostanolone,
fenoterol, fluoxymesterone,
formebolone, formoterol,
gestrinone, mesterolone,
metandienone, metenolone,
methandriol, methyltestosterone,
mibolerone, nandrolone,
19-norandrostenediol, 19-norandrostenedione, norethandrolone,
oxandrolone, oxymesterone,
oxymetholone, reproterol,
salbutamol, salmeterol,
stanozolol, terbutaline,
testosterone, trenbolone,
DIURETICS
acetazolamide, bendroflumethiazide,
bumetanide, canrenone, chlortalidone, ethacrynic
acid, furosemide, hydrochlorothiazide, indapamide, mannitol (by
intravenous injection), mersalyl, spironolactone, triamterene,
MASKING AGENTS
bromantan, diuretics (see above), epitestosterone, probenecid,
PEPTIDE HORMONES, MIMETICS AND ANALOGUESo7
ACTH, erythropoietin (EPO), hCG*, hGH, insulin, LH*, clomiphene*,
cyclofenil*, tamoxifen*,
* prohibited in males only
BETA BLOCKERS
acebutolol, alprenolol,
atenolol, betaxolol, bisoprolol, bunolol, carteolol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol.
V. ADDITIONAL REGULATIONS
[Cf. Art. 2 II.] Appendix B: Forms of Consent
1. I hereby agree to the terms of the IDSF Anti-Doping Code and
agree to submit to those terms. I am aware that if I violate the
Anti-Doping Code, I may be subject to severe disciplinary sanctions
according to this Code. A copy of the IDSF Anti-Doping Code has been handed
out to me.
(Signature; for minors signature of a parent)
2. I submit to the regulations of the International Court of
Arbitration for Sports, Lausanne,
Switzerland.
(Signature; for minors signature of a parent)
3. I understand that by signing this form I am granting my consent
to a urine or/and blood sample being taken from me. I understand that the
urine or/and blood sample is to be taken so that it may be analysed to determine whether it discloses the presence
of any substances prohibited under the IDSF Anti-Doping Code, and that if
the analysis of the sample reveals the presence of any such substance, or
deviations from the normal range in the case of endogenous substances, I
may be subject to disciplinary sanctions under the rules of the IDSF
Anti-Doping Code. I also understand that the analysis of my sample might
reveal evidence of disease. In such an instance I grant consent for the
appropriate information to be sent to me via the IDSF or my national DanceSport federation, provided such information shall
remain confidential to the laboratory and myself and shall be contained
within an envelope sealed by the laboratory and bearing only my sample code
number.
(Signature; for minors signature of a parent)
APPROVED
BY THE 2001 IDSF GENERAL MEETING EFFECTIVE JANUARY 1, 2002.
BY ORDER OF THE IDSF GENERAL MEETING AND THE IDSF PRESIDIUM
|
Back to top
|
